Hormone receptor positive HER2 negative breast cancer
Not yet recruitingStudy on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain
Study on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain
- Disease:Hormone receptor positive HER2 negative breast cancer
- Substances:DuloxetineFurosemide+1
Spain- Participants:18–64 years · 65+ years
- Substances:Duloxetine
- Sponsor:European Organisation For Research And Treatment Of Cancer









